NIM
MRNA icon

Northeast Investment Management’s Moderna MRNA Stock Holding History

Northeast Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,893
Closed -$985K – 178
2022
Q2 		$985K Sell
6,893
-99
-1% -$14.2K 0.06% 99
2022
Q1 		$1.2M Sell
6,992
-1,120
-14% -$189K 0.06% 105
2021
Q4 		$2.06M Sell
8,112
-3,723
-31% -$1.09M 0.1% 91
2021
Q3 		$4.55M Buy
11,835
+433
+4% +$160K 0.24% 64
2021
Q2 		$2.68M Buy
11,402
+650
+6% +$116K 0.14% 84
2021
Q1 		$1.41M Hold
10,752
– – 0.08% 97
2020
Q4 		$1.12M Sell
10,752
-12
-0.1% -$1.21K 0.07% 102
2020
Q3 		$762K Sell
10,764
-60
-0.6% -$4.18K 0.05% 109
2020
Q2 		$695K Buy
+10,824
New +$593K 0.05% 102

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northeast Investment Management's MRNA Position: Q3 2022 in Review

Northeast Investment Management sold out of Moderna (MRNA) in Q3 2022, closing a stake of 6,893 shares — an estimated $985K sold.

Northeast Investment Management first reported a position in MRNA in Q2 2020 and held it in 9 quarters. The position peaked at $4.55M in Q3 2021. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Northeast Investment Management reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Northeast Investment Management sold 6,893 Moderna shares in Q3 2022, an estimated $985K.
  • Northeast Investment Management first reported a position in Moderna in Q2 2020 and held it in 9 quarters.
  • Northeast Investment Management's Moderna position peaked at $4.55M in Q3 2021.
  • 916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Northeast Investment Management's 13F filing for Q3 2022, filed 28 Oct 2022.